A clinical review in this week’s issue of the British Medical Journal (BMJ) states clearly that “Prostate cancer screening with the PSA blood test results in at most a small reduction in prostate cancer mortality and leads to considerable diagnostic and treatment related harms” and that “Physicians should recommend against PSA screening for prostate cancer.” … READ MORE …
Filed under: Diagnosis, Risk | Tagged: Diagnosis, PSA, risk, screening, testing | 4 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site